Let's Find Opportunities Overseas

Tag: Institutional Ownership

Cartoon-style illustration of a confident CEO in a bright safety vest standing atop a mountain of cash-filled garbage bags beside futuristic Waste Connections garbage trucks, while Wall Street analysts stare in disbelief.

🚛 Waste Connections (WCN): Trading Trash for Pure Cash

Waste Connections (WCN) may operate in garbage, but its business model is pure gold. After a 23% pullback from all-time highs, founder-CEO Ronald Mittelstaedt just bought $7.6 million worth of shares in the open market. With elite margins, recession-resistant cash flow, institutional dominance, and almost zero short sellers, WCN looks less like a trash company and more like a compounding machine disguised as a dump truck.

Read entire article

Futuristic illustration of Novocure’s wearable cancer-treatment technology emitting electric waves around a patient’s abdomen, symbolizing its FDA-approved pancreatic cancer therapy and NVCR stock’s high-risk, high-upside potential.

NVCR Stock Analysis 2026: Is Novocure’s Pancreatic Cancer Breakthrough a Buy?

Novocure is trying to fight cancer with electric fields, not pills — and its new FDA approval in pancreatic cancer may be the catalyst that changes everything. NVCR remains speculative, but with heavy institutional backing, improving fundamentals, and a beaten-down stock price, the risk/reward is getting harder to ignore.

Read entire article

A cartoon-style illustration of a yoga mat unrolling into a stock chart, with a confident CEO doing warrior pose on top of LULU shares, surrounded by bullish whales in workout gear and a bear tripping over yoga blocks labeled “20% drop.”

Lululemon: Don’t Sweat the Small Stuff

Lululemon shares just faceplanted—down 20%—but insiders (and leggings lovers) may see a bounce coming. From CEO buys to global growth and cult-level brand loyalty, here’s why LULU might be worth the stretch. 🧘💰

Read entire article